Navigation Links
REACH news: European ombudsman takes up PETA complaint
Date:1/30/2013

London In response to a complaint by People for the Ethical Treatment of Animals (PETA), the European Ombudsman has launched an inquiry into the actions of the European Union (EU) agency responsible for the administration of the REACH chemical-testing program, which is expected to consume millions of animals in toxicity tests. PETA's complaint, submitted in July 2012, alleges that the European Chemicals Agency (ECHA) is not properly investigating cases in which animal testing could be avoided under the rules of REACH. PETA maintains that evidence derived from public documents and correspondence with the agency demonstrates that ECHA is not taking the necessary steps to ensure fulfilment of REACH's legal requirement that animal testing be conducted only as a "last resort."

The REACH Regulation (1907/2006/EU) makes clear in recitals, articles and annexes that animal tests must be avoided whenever possible, but in 2011 the agency's report "The Use of Alternatives to Testing on Animals for the REACH Regulation" showed that tens of thousands of animals were used in tests that could have been avoided under REACH's own rules. These tests included 135 skin-irritation studies conducted after a non-animal replacement had been validated and approved for use under REACH and 107 studies conducted without prior submission and approval of a testing proposal.

In response to the report, PETA contacted ECHA and the European Commission to seek assurances that all such possible violations of the requirements were being investigated by the agency and/or reported to relevant national authorities. PETA's enquiries have revealed that ECHA is not taking action to investigate all the 107 tests on animals conducted without test proposals, does not directly inform member state authorities of all possible violations of last-resort requirements and does not assess information dossiers submitted by chemical companies to evaluate whether animal tests undertaken for REACH could have been avoided.

In its complaint, PETA argued that in failing to properly evaluate whether animal tests had been conducted as a last resort in accordance with REACH's requirements, ECHA was guilty of maladministration. It is this complaint which the Ombudsman took up in December.

"PETA alleges that animals may have been poisoned and killed in tests that should never have taken place," says PETA UK Science Adviser Dr Gilly Stoddart. "We are relieved that the Ombudsman has launched an inquiry, as the lives of millions of animals are at stake. We trust that the Ombudsman will share our view and compel the agency to fulfil its obligations."


'/>"/>

Contact: Tasgola Bruner
TasgolaB@peta.org
770-518-1675
People for the Ethical Treatment of Animals
Source:Eurekalert

Related biology news :

1. ImpactStory metrics of academic research outreach piloted by Pensoft Publishers
2. A call to prevent unsafe high-risk medical devices from reaching the marketplace
3. Nanoparticles reach new peaks
4. GEOLOGY returns to Naica Cave, Mexico, and extends its reach to Mercury
5. $1 million Kenan Trust Grant extends support of Scripps Florida education outreach
6. Crank Software Selects TREW Marketing for Embedded Industry Outreach
7. Global Market for Nanotechnology to Reach $3.3 Trillion by 2018
8. New public gut bacteria study expected to reach around world
9. Airborne particles smuggle pollutants to far reaches of globe
10. Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn
11. Sea surface temperatures reach record highs on Northeast continental shelf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
Breaking Biology Technology: